Home » Biotechnology » High Content Screening Market

High Content Screening Market By Product (Instruments, Consumables, Software, Services, Accessories), By Application (Target Identification And Validation, Primary Screening And Secondary Screening, Toxicity Studies, Compound Profiling) – Growth, Share, Opportunities & Competitive Analysis, 2017 – 2025

Summary
Table Of Content

Market Insights

Global High Content Screening Market by Product (Instruments, Consumables, Software, Services, and Accessories) and Application (Target Identification and Validation, Primary and Secondary Screening, Toxicity Studies, Compound Profiling, and Others) – Market Growth, Future Prospects, and Competitive Analysis, 2017-2025

The most established approach for the multi-parametric analysis of cellular events is high-content screening. For example, the citation 5-cell imaging multi-mode reader combines automated digital wide-field microscopy with conventional multi-mode microplate reading and can capture qualitative information about phenotypic cellular information in a single experiment. It has undergone tremendous technological advancements over the last decade, and HCS imaging systems are expected to evolve continuously throughout the forecast period to offer greater flexibility and meet the requirements of assays involving complex cellular disease models. High-content screening has rising demands for the analysis of 3D spheroids and microtissues and phenotypic assays; it will have a huge impact in the near future on gene editing studies based on CRISP-Cas9.

For the purpose of this study, the various products studied include instruments, consumables, software, services, and accessories. The applications are classified as target identification and validation, primary screening and secondary screening, toxicity studies, compound profiling, and others. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

The global high-content screening market is segmented geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global high-content screening market. Competition assessment tools such as Porter’s five forces analysis, market attractiveness assessment, and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the global high-content screening market. The key players profiled in this report are Becton Dickinson and Company, Bio-Rad Laboratories, BioTek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore Corporation, Olympus Corporation, Perkin Elmer, Inc., Tecan Group, Yokogawa Electric Corporation.

Based on product, the global high-content screening market is categorized into

Instruments
Cell Imaging and Analysis System
Flow Cytometers
Consumables
Reagents and Assay kits
Microplates
Other Consumables
Software
Services
Accessories

The high-content screening market is driven by factors such as the rising need for cost containment in pharmaceutical research and development and enhanced funding in proteomics. In addition, the technological advancement in the techniques employed, such as flow cytometry, automated imaging technology, and the use of multicolored fluorescence-based reagents, will propel the deep market penetration for high content screening. In 2016, the instrument segment held the largest market share chiefly due to factors such as technological advancement in automation techniques and phenotypic screening and found huge applications in biopharmaceuticals, contract research organizations, research institutes, etc. The software will be the fastest growing market throughout the forecast period 2017-2025, majorly due to its application in obtaining a multi-parametric analysis of cellular events and assisting in obtaining image processing and visualization tools to extract quantitative data from cell populations. The major players in the high content screening market are Becton Dickinson and Company, Bio-Rad Laboratories, BioTek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore Corporation, Olympus Corporation, Perkin Elmer, Inc., Tecan Group and Yokogawa Electric Corporation.

Based on application, the global high-content screening market is categorized into

Target Identification and Validation
Primary Screening and Secondary Screening
Toxicity Studies
Compound Profiling
Others

The high content screening is witnessing tremendous growth significantly due to the increasing need to launch novel drug molecules owing to the presence of outdated drug therapy regimens with ineffective pharmacodynamic profiles. Additionally, the a burgeoning requirement to promote intensive treatment of chronic diseases such as cardiovascular complications, diabetes, Alzheimer’s, Parkinson’s, cancer, etc. Drug toxicity screening is necessary for new drug application (NDA) and clinical trial approval before the drug enters the market. In 2016, target identification and validation and primary and secondary screening both dominated the market mainly due to factors such as the increasing number of biosimilars and biological drug candidates in the market requiring primary and secondary screening to prove drug efficacy and safety. Additionally, the Hope Act (2013) signed by US government to encourage the development of novel therapies for children with rare diseases will employ target identification and validation to determine the approach for drug discovery and development. The toxicity studies segment is anticipated to register faster growth throughout the forecast period 2017-2025, majorly due to the rising incidence of drug-related adverse events, the increased risk associated with the toxic metabolites produced by the drug biotransformation process, and stringent regulatory norms by USFDA to enhance the drug toxicity screening in the drug clinical trial phase.

For the purpose of this study, the global high-content screening market is categorized into the following regional and country-specific markets:

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

North America was observed to be the largest market for high-content screening in the base year 2016. The dominance of North America is mainly attributed to the presence of key pharmaceutical players focusing on novel drug discovery and enhanced government spending in the research and development facilities in healthcare institutions. The market growth in Europe is mainly attributed to the increasing number of patients suffering from rare diseases such as Gaucher disease, Pompe disease, or multiple sclerosis. This factor boosts the demand for phenotypic drug screening and technological advancement in the instruments employed for image analysis and data collection for cellular activities. Asia Pacific was observed as the fastest-growing regional segment throughout the forecast period 2017-2025. Factors that are anticipated to propel the market growth are the presence of a large patient pool that can be enrolled to study drug toxicity studies for drug clinical trials, a competitive market due to the presence of existing major players and evolving biopharmaceutical and medical imaging manufacturers in these regions, and supportive regulatory environment for high content screening products. Moreover, factors such as developing health infrastructure and a public-private partnership between major pharma players and government agencies are going to fuel the rapid growth of the high-content screening market in Latin America and the Middle East and Africa region in the near future.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global High Content Screening Market Portraiture
2.1.1. Global High Content Screening Market, by Product, 2016
2.1.2. Global High Content Screening Market, by Application, 2016
2.1.3. Global High Content Screening Market, by Geography, 2016

Chapter 3. High Content Screening Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Prevalence Data of Major Target Diseases
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Porter’s Five Forces Analysis
3.7. Attractive Investment Proposition, by Geography
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global High Content Screening Market, by Product
4.3. Instruments
4.3.1. Cell Imaging and Analysis System
4.3.2. Flow Cytometers
4.4. Consumables
4.4.1. Reagents and Assay Kits
4.4.2. Microplates
4.4.3. Other Consumables
4.5. Software
4.6. Services
4.7. Accessories

Chapter 5. Global High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Attractive Investment Proposition: Global High Content Screening Market, by Application
5.3. Target Identification and Validation
5.4. Primary Screening and Secondary Screening
5.5. Toxicity Studies
5.6. Compound Profiling
5.7. Others

Chapter 6. Global High Content Screening Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America High Content Screening Market Analysis, 2015 – 2025
6.2.1. North America High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
6.2.2. North America High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
6.2.3. North America High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe High Content Screening Market Analysis, 2015 – 2025
6.3.1. Europe High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
6.3.2. Europe High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
6.3.3. Europe High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. France
6.3.3.4. Rest of Europe
6.4. Asia Pacific High Content Screening Market Analysis, 2015 – 2025
6.4.1. Asia Pacific High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of APAC
6.5. Latin America High Content Screening Market Analysis, 2015 – 2025
6.5.1. Latin America High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
6.5.2. Latin America High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
6.5.3. Latin America High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) High Content Screening Market Analysis, 2015 – 2025
6.6.1. MEA High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
6.6.2. MEA High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
6.6.3. MEA High Content Screening Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Becton Dickinson and Company
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Bio-Rad Laboratories, Inc.
7.3. BioTek Instruments, Inc.
7.4. Danaher Corporation
7.5. GE Healthcare
7.6. Merck Millipore Corporation
7.7. Olympus Corporation
7.8. Perkin Elmer, Inc.
7.9. Tecan Group
7.10. Yokogawa Electric Corporation

List of Figures

FIG. 1 High Content Screening: Market Segmentation
FIG. 2 Global High Content Screening Market Share, by Product, 2016 (Value %)
FIG. 3 Global High Content Screening Market Share, by Application, 2016 (Value %)
FIG. 4 Global High Content Screening Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Cell Imaging and Analysis System Market 2015 – 2025 (US$ Mn)
FIG. 8 Global Flow Cytometers Market 2015 – 2025 (US$ Mn)
FIG. 9 Global Reagents and Assay Kits Market 2015 – 2025 (US$ Mn)
FIG. 10 Global Microplates Market 2015 – 2025 (US$ Mn)
FIG. 11 Global Other Consumables High Content Screening Market 2015 – 2025 (US$ Mn)
FIG. 12 Global Software Market 2015 – 2025 (US$ Mn)
FIG. 13 Global Services Market 2015 – 2025 (US$ Mn)
FIG. 14 Global Accessories Market 2015 – 2025 (US$ Mn)
FIG. 15 Global Target Identification and Validation Market 2015 – 2025 (US$ Mn)
FIG. 16 Global Primary Screening and Secondary Screening Market 2015 – 2025 (US$ Mn)
FIG. 17 Global Toxicity Studies Market 2015 – 2025 (US$ Mn)
FIG. 18 Global Compound Profiling Market 2015 – 2025 (US$ Mn)
FIG. 19 Global Others High Content Screening Application Market 2015 – 2025 (US$ Mn)
FIG. 20 U.S. High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 21 Canada High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 22 U.K. High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 23 Germany High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 24 France High Content Screening Market, 2015-2025 (US$ Mn)
FIG. 25 Rest of Europe High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 26 Japan High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 27 China High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 28 India High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 29 Rest of Asia Pacific High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 30 Brazil High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 31 Mexico High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 32 Rest of Latin America High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 33 GCC High Content Screening Market, 2015 – 2025 (US$ Mn)
FIG. 34 Rest of Middle East and Africa High Content Screening Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 2 Global Instruments Market, 2015 – 2025 (US$ Mn)
TABLE 3 Global Consumables Market, 2015 – 2025 (US$ Mn)
TABLE 4 Global High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 5 Global High Content Screening Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 6 North America High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 7 North America High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 8 North America High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 10 Europe High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 11 Europe High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America High Content Screening Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 18 Middle East and Africa High Content Screening Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 19 Middle East and Africa High Content Screening Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa High Content Screening Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 21 Becton Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 BioTek Instruments, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 GE Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Merck Millipore Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Olympus Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Perkin Elmer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Tecan Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Yokogawa Electric Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Frequently Asked Questions

What is the size of High Content Screening Market?

The market for High Content Screening is expected to reach US$ 1,988.1 Mn in 2025.

What is the High Content Screening Market CAGR?

The High Content Screening market is expected to see significant CAGR growth over the coming years,at 5.82%.

What is the Forecast period considered for High Content Screening Market?

The report is forecasted from 2017-2025.What is the base year considered for High Content Screening Market?

What is the base year considered for High Content Screening Market?

The base year of this report is 2016.

Who are the major players in this Market?

Becton Dickinson and Company,Bio-Rad Laboratories Inc.,BioTek Instruments, Inc.,Danaher Corporation,GE Healthcare are some of the major players in the global market.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –